Urinary Tract Disease

Paid Clinical Trials and Focus Groups



Find Paid Clinical Trials

Paid Clinical Trials - : Urinary Tract Disease




  • Condition:   Urinary Tract Infection
    Interventions:   Drug: ertapenem sodium;   Drug: Comparator: ceftriaxone sodium
    Sponsor:   Merck
    Completed - verified November 2009

  • Condition:   Blood Pressure
    Intervention:   Other: DASH, Control
    Sponsors:   Duke University;   American Heart Association
    Completed - verified November 2009

  • Conditions:   Bladder Exstrophy;   Urinary Incontinence
    Intervention:   Drug: MDC
    Sponsor:   Johns Hopkins University
    Not yet recruiting - verified November 2009

  • Conditions:   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: anti-CCR2 monoclonal antibody MLN1202;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009

  • Conditions:   Stomach Cancer;   Gall Bladder Cancer;   Bile Ductus Cancer;   Pancreas Cancer;   Colorectal Cancer
    Intervention:   Other: oxaliplatin, capecitabine, radiotherapy
    Sponsors:   Lund University Hospital;   Roche Pharma AG;   Sanofi-Synthelabo
    Completed - verified November 2009

  • Conditions:   Bladder Cancer;   Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: docetaxel;   Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Active, not recruiting - verified November 2009

  • Condition:   Lupus Nephritis
    Interventions:   Drug: mycophenolate sodium;   Drug: cyclophosphamide
    Sponsors:   Chulalongkorn University;   Clinical Research Collaborative Network;   Health Intervention and Technology Assessment Program (HITAP)
    Not yet recruiting - verified November 2009

  • Conditions:   Diabetic Nephropathy;   Proteinuria
    Interventions:   Drug: Turmeric extract;   Drug: Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker
    Sponsors:   Shaheed Faghihi Hospital;   Shiraz University of Medical Sciences
    Completed - verified November 2009

  • Condition:   Urinary Calculus
    Intervention:   Drug: progesterone,tamsulosin,propantheline Bromide and nifedipine
    Sponsor:   Chongqing Medical University
    Recruiting - verified November 2009

  • Condition:   Stress Urinary Incontinence Cell Therapy
    Intervention:   Biological: Autologous Muscle Derived Cells
    Sponsor:   Cook
    Not yet recruiting - verified November 2009

  • Condition:   Hyperalgesia, Secondary
    Interventions:   Procedure: TAP Block;   Procedure: TAP Block;   Procedure: TAP Block
    Sponsor:   University of Washington
    Recruiting - verified November 2009

  • Condition:   Bladder Cancer
    Interventions:   Procedure: Studer Pouch orthotopic urinary diversion;   Procedure: T-Pouch orthotopic urinary diversion
    Sponsor:   USC/Norris Comprehensive Cancer Center
    Recruiting - verified November 2009

  • Condition:   Healthy
    Intervention:   Dietary Supplement: broccoli sprouts extract
    Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Qidong Liver Cancer Institute
    Active, not recruiting - verified November 2009

  • Conditions:   Urgency Frequency;   Urinary Urge Incontinence
    Intervention:   Device: InterStim Therapy
    Sponsor:   MedtronicNeuro
    Recruiting - verified November 2009

  • Condition:   Healthy Volunteers
    Interventions:   Drug: PF-04531083 or Placebo;   Drug: PF-04531083 or Placebo;   Drug: PF-04531083 or Placebo;   Drug: PF-04531083 or Placebo
    Sponsor:   Pfizer
    Not yet recruiting - verified November 2009

  • Condition:   Bladder Cancer
    Intervention:  
    Sponsors:   M.D. Anderson Cancer Center;   Flight Attendant Medical Research Institute
    Recruiting - verified November 2009

  • Condition:   Gall Bladder Stone in Cirrhotics
    Interventions:   Procedure: LC was done using traditional method;   Procedure: LC was done using harmonic ACE
    Sponsor:   Mansoura University
    Completed - verified November 2009

  • Condition:   Polycystic Kidney Diseases
    Interventions:   Drug: Everolimus;   Drug: Standard Therapy
    Sponsor:   A. Manzoni Hospital
    Recruiting - verified November 2009

  • Condition:   Prostate Cancer
    Interventions:   Dietary Supplement: tomato-soy juice;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: therapeutic conventional surgery
    Sponsors:   Arthur G. James Cancer Hospital & Richard J. Solove Research Institute;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Condition:   Hypercalciuria
    Interventions:   Behavioral: Low salt diet;   Behavioral: Water therapy alone
    Sponsors:   University of Parma;   Università Vita-Salute San Raffaele;   University of Milan;   Catholic University of the Sacred Heart
    Completed - verified October 2009

  • Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
    Interventions:   Drug: L-O-M® MCS 15 mg/day;   Drug: L-O-M® MCS 30 mg/day;   Drug: Placebo
    Sponsor:   Health Ever Bio-Tech Co., Ltd.
    Not yet recruiting - verified October 2009

  • Condition:   Fecal Incontinence
    Intervention:   Biological: ANT-SM
    Sponsor:   Anterogen Co., Ltd.
    Recruiting - verified November 2009

  • Condition:   Methamphetamine Dependence
    Interventions:   Dietary Supplement: CDP-choline;   Dietary Supplement: Placebo (fructose)
    Sponsor:   Seoul National University Hospital
    Not yet recruiting - verified November 2009

  • Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
    Intervention:   Drug: L-O-M MCS
    Sponsor:   Health Ever Bio-Tech Co., Ltd.
    Not yet recruiting - verified October 2009

  • Condition:   Diabetic Nephropathy
    Interventions:   Drug: placebo;   Drug: Milk Thistle extract
    Sponsor:   Shiraz University of Medical Sciences
    Not yet recruiting - verified November 2009

  • Condition:   Overactive Bladder
    Intervention:   Drug: KUC-7483
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Condition:   Overactive Bladder
    Interventions:   Drug: KUC-7483;   Drug: Placebo;   Drug: Tolterodine
    Sponsor:   Kissei Pharmaceutical Co., Ltd.
    Recruiting - verified October 2009

  • Conditions:   Overactive Bladder;   Constipation;   Lower Urinary Tract Symptoms
    Interventions:   Drug: Baclofen;   Drug: Placebo Comparator: Placebo
    Sponsor:   Wake Forest University
    Recruiting - verified October 2009

  • Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
    Intervention:   Drug: L-O-M MCS
    Sponsor:   Health Ever Bio-Tech Co., Ltd.
    Not yet recruiting - verified October 2009

  • Condition:   Osteoporosis
    Interventions:   Dietary Supplement: Small Particle Size Calcium Carbonate Supplement;   Dietary Supplement: Large Particle Size Calcium Carbonate Supplement;   Dietary Supplement: Vitamin D;   Dietary Supplement: Calcium Placebo
    Sponsor:   Purdue University
    Completed - verified October 2009

  • Conditions:   Renal Calculi;   Ureteral Calculi
    Intervention:  
    Sponsor:   Assaf-Harofeh Medical Center
    Not yet recruiting - verified March 2009

  • Condition:   Non Muscle Invasive Bladder Cancer
    Interventions:   Procedure: NBI TUR;   Procedure: Standard TUR
    Sponsor:   National Institute for Cancer Research, Italy
    Recruiting - verified October 2009

  • Condition:   Asthma
    Intervention:   Drug: Etoricoxib
    Sponsors:   Karolinska University Hospital;   Karolinska Institutet
    Recruiting - verified October 2009
  • Find Paid Clinical Trials